Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Big pharma trying to quash CA drug price cap effort with massive campaign war chest
BioPharma Dive
Fri, 11/20/15 - 10:55 am
Tags:
California, drug pricing, JNJ, AbbVie, Amgen, Eli Lilly, Bristol-Myers Squibb
Gilead Sciences: AbbVie, Merck Fail to ‘Mount a Major Threat’
Barron's
Wed, 11/18/15 - 03:53 pm
Tags:
Gilead Sciences, AbbVie, Merck, hepatitis C
AbbVie's Humira repeats, joined by BMS' Opdivo in leading TV spending for October
Fierce Pharma Marketing
Wed, 11/18/15 - 09:42 am
Tags:
AbbVie, Humira, Bristol-Myers Squibb, Opdivo, drug ads
AbbVie Announces New Data on VIEKIRA PAK® (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Patients with Chronic Hepatitis C Virus Infection With or Without Compensated Cirrhosis
Yahoo
Sat, 11/14/15 - 11:33 am
Tags:
AbbVie, Viekira Pak, hepatitis C
AbbVie Submits IMBRUVICA® (ibrutinib) Phase III Combination Data to U.S. FDA
Yahoo
Fri, 11/13/15 - 10:59 am
Tags:
AbbVie, Imbruvica, bendamustine, rituximab, chronic lymphocytic leukemia, FDA
Merck & Co. Versus AbbVie: Who Is the Winner and Who Is the Loser?
Yahoo/GuruFocus
Thu, 11/12/15 - 01:40 pm
Tags:
Merck, AbbVie
AbbVie Humira Patent Loss To Be Biggest Ever In History
Bidness, ETC
Mon, 11/9/15 - 09:48 pm
Tags:
AbbVie, Humira, patents, generics
Gilead, AbbVie Asked by U.S. for Hepatitis C Pricing Options
Bloomberg
Thu, 11/5/15 - 08:58 pm
Tags:
Gilead Sciences, AbbVie, drug pricing, hepatitis C
Express Scripts to put specialty pharmas under the microscope, focusing on Teva & AbbVie
BioPharma Dive
Tue, 11/3/15 - 05:44 pm
Tags:
Express Scripts, specialty pharma, Teva, AbbVie
South Africa Asked to Allow Generics for AbbVie HIV Drug
Bloomberg
Mon, 11/2/15 - 08:19 am
Tags:
South Africa, HIV, generics, AbbVie, Lopinavir
AbbVie Calms Humira Biosimilar Fears
WSJ Online
Mon, 11/2/15 - 08:08 am
Tags:
AbbVie, Humira, biosimilars
AbbVie Beats Estimates, Forecasts Double-Digit Growth to 2020
Bloomberg
Fri, 10/30/15 - 09:46 am
Tags:
AbbVie, earnings
What to Look For in AbbVie Earnings
24/7 Wall St
Thu, 10/29/15 - 01:29 pm
Tags:
AbbVie, earnings
Express Scripts to maintain availability of AbbVie's hep C drug
Yahoo/Reuters
Wed, 10/28/15 - 02:58 pm
Tags:
Express Scripts, AbbVie, hepatitis C, Viekira Pak
Merck says it won't need AbbVie-sized discounts to win in hep C
Fierce Pharma Marketing
Wed, 10/28/15 - 09:56 am
Tags:
Merck, AbbVie, hepatitis C
If It Happened To AbbVie, Could It Also Happen To Gilead?
Seeking Alpha
Mon, 10/26/15 - 09:40 pm
Tags:
AbbVie, Gilead Sciences, hepatitis C
Gilead: A Winner On 3 Fronts
Seeking Alpha
Sun, 10/25/15 - 06:28 pm
Tags:
Gilead Sciences, AbbVie, hepatitis C
8 BioPharma Movers That Cannot Be Ignored
24/7 Wall St
Sat, 10/24/15 - 02:28 pm
Tags:
AbbVie, Gilead Sciences, Endo International, Synta Pharmaceuticals, Valeant Pharmaceuticals, Relypsa, Repros Therapeutics, Ocular Therapeutix
FDA's Warning Shakes Up Hep C Landscape
Investopedia
Fri, 10/23/15 - 05:08 pm
Tags:
FDA, warnings, hepatitis C, AbbVie, Gilead Sciences, Harvoni, Viekira Pak
How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead
24/7 Wall St
Fri, 10/23/15 - 11:08 am
Tags:
FDA, Gilead Sciences, AbbVie, hepatitis C, warnings, Viekira Pak, Technivie

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.